Woebot Health Raises $90M in Series B Funding

Woebot Health

Woebot Health, a San Francisco, CA-based creator of relational tools and technologies for mental health, raised $90m in Series B funding.

The round, which brought total funding raised to date to $114m, was co-led by existing investor Jazz Venture Partners and Temasek with participation from funds and accounts managed by BlackRock Private Equity Partners and Owl Ventures, Mirae Asset Capital, Kicker Ventures, Alumni Ventures and Gaingels as well as existing investors NEA and AI Fund.

The company intends to use the funds to accelerate further development of its relational platform and technologies, advance its lead digital therapeutic candidates, and expand its team and go-to-market activities.

Founded in 2017 and led by Chief Executive Officer Michael Evers, Woebot Health has created relational technologies that underpin a new generation of digital therapeutics and tools for mental health. Core to its artificial intelligence (AI)-powered health platform is Woebot, a relational agent that translates proven therapeutic approaches into software applications, which can be an integral part of a comprehensive ecosystem of care.